{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-004783","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2024-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.240637+00:00","generated_at":"2026-06-06T10:27:43.116238+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oncotelic completes $0.5M debt conversion and issues 12 convertible note units","bullets":["Issued 12 units each with a $25,000 convertible note (convertible at $0.10/share) and warrants to buy 250,000 shares at $0.12/share.","Converted $500,000 of debt from 4 accredited investors under prior private placement into Subscription Agreements.","Paid $45,000 placement agent fees to JH Darbie & Co., which also earned 13% of warrants issued.","This fourth tranche concludes conversion of all notes from prior private placement; company hopes to raise additional funds."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-004783","json":"https://secwatch.observer/filing/0001493152-24-004783.json","markdown":"https://secwatch.observer/filing/0001493152-24-004783.md","text":"https://secwatch.observer/filing/0001493152-24-004783.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315224004783/0001493152-24-004783-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315224004783/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T10:27:43.116238+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}